Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Initiation of Phase II Study of naronapride in patients with gastroparesis

Randomized, double-blind, placebo-controlled study to evaluate efficacy of novel pan-GI prokinetic in patients with gastroparesis Renexxion Ireland Limited, a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need in gastrointestinal (“GI”) disorders, is pleased to announce that the first patient has been treated in Europe with naronapride, a potential best-in-class […]

thaipr.net

16 ก.พ. 66

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon. The Magic Touch PTA Sirolimus Coated Balloon Catheter is indicated for the treatment of Below the Knee (BTK) atherosclerotic lesions in Peripheral Arterial Disease. CMI received their first IDE approval for their Magic Touch Sirolimus Coated […]

thaipr.net

14 ก.พ. 66

U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax’ COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a modification to its existing agreement with the U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense, to deliver up to 1.5 million doses of the Novavax COVID-19 Vaccine, […]

thaipr.net

14 ก.พ. 66

Syntach AB announces partnership with Meditrial CRO to drive clinical development of groundbreaking Cardiac Support System

Syntach AB (“Syntach”) is pleased to announce that it has entered into a partnership agreement with Meditrial Europe Ltd (“Meditrial”) to support the clinical and regulatory strategies of Syntach’s innovative minimally invasive cardiac support system. Over 64 million people suffer from heart failure, one of the most common causes of death globally. Syntach Cardiac Support […]

thaipr.net

13 ก.พ. 66

Esaote presents the world premiere of its new MyLab™X90 ultrasound device

An innovative premium system combining outstanding performance with artificial intelligence to optimize workflows and support advanced and interconnected healthcare systems Today Esaote, a leading Italian company in the biomedical sector – in ultrasound, dedicated MRI and medical IT– presents the world premiere of MyLab™X90, its new premium ultrasound system. “Accuracy and precision across the entire image generation chain, […]

thaipr.net

3 ก.พ. 66

Accelerating Energy Efficiency Adoption, Deep-tech Startup KrossLinker Develops a Cost-effective Aerogel Insulation

KrossLinker, an energy-efficiency-focused deep-tech advanced material startup, is designing and developing the world’s most insulating nanomaterial, aerogel, that is low-cost, environmentally friendly, and scalable. Efficient and sustainable solutions for the most demanding insulation applications KrossLinker’s first aerogel product, Cryar® Aerogel Board, targets the cold-chain industry, where a positive market growth trend is…

thaipr.net

2 ก.พ. 66

Syntach AB announces €17.5M in Blended Funding, Names Patrick NJ Schnegelsberg as New CEO, and Appoints Cansel Isikli as VP of RA/Q

Swedish medtech startup Syntach AB has been awarded up to €15 million in equity financing by European Innovation Council (EIC) for the development of the Syntach Cardiac Support System, a breakthrough device for patients with heart failure. This approval follows the award of a €2.5 million grant from the EIC announced by Syntach AB in […]

thaipr.net

1 ก.พ. 66

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer

The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, announced today that the U.S. Food and Drug Administration (FDA) has approved ORSERDU for the treatment of postmenopausal women or adult men, with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. Stemline Therapeutics (“Stemline”), a […]

thaipr.net

1 ก.พ. 66
1 16 17 18 19 20 73